Epidemiology and clinical manifestations of SARS-CoV2 infection
Descripción del Articulo
Over the last year, the whole world has been affected by the COVID-19 pandemic, with over 80 million people affected with more than 1.8 million dead over the same period. Like other recent epidemics, this seems to be zoonotic in origin with the bats as the primary species harboring these coronavirus...
| Autor: | |
|---|---|
| Formato: | artículo |
| Fecha de Publicación: | 2021 |
| Institución: | Fundación Instituto Hipólito Unanue |
| Repositorio: | Diagnóstico |
| Lenguaje: | español |
| OAI Identifier: | oai:revistadiagnostico.fihu.org.pe:article/255 |
| Enlace del recurso: | https://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/255 |
| Nivel de acceso: | acceso abierto |
| Materia: | Pandemia COVID-19 pandemia |
| id |
REVFIHU_28e5036b0daf128b132076da4b8b4fbc |
|---|---|
| oai_identifier_str |
oai:revistadiagnostico.fihu.org.pe:article/255 |
| network_acronym_str |
REVFIHU |
| network_name_str |
Diagnóstico |
| repository_id_str |
|
| spelling |
Epidemiology and clinical manifestations of SARS-CoV2 infectionEpidemiología y manifestaciones clínicas de la infección por SARS-CoV-2Espinoza, Luis A.PandemiaCOVID-19COVID-19pandemiaOver the last year, the whole world has been affected by the COVID-19 pandemic, with over 80 million people affected with more than 1.8 million dead over the same period. Like other recent epidemics, this seems to be zoonotic in origin with the bats as the primary species harboring these coronaviruses but with a still unnamed intermediary host. Up to 80% of the cases have minor symptoms but 5% of the remainder may develop severe complications including respiratory failure. There has been a fast development of the knowledge about the disease in a very short period of time, making it a less lethal disease now as well as accelerating the development of several available vaccines.En el último año la pandemia desatada por el COVID-19 ha afectado todos los territorios del mundo con más de 80 millones de casos y una mortalidad superior a 1.8 millones de personas. Al igual que otras recientes epidemias, esta epidemia de origen zoonótico parece haberse originado en los murciélagos aunque no se ha determinado el huésped intermedio. La mayoría de los casos, hasta en un 80%, parecen tener síntomas menores pero hasta un 5% del resto pueden hacer enfermedad severa incluyendo falla respiratoria. El avance en el conocimiento de la enfermedad ha permitido que la mortalidad sea menor que al inicio de la pandemia y también en el desarrollo de algunas vacunas efectivas en un tiempo no visto antes en la historia de la medicina.Fundación Instituto Hipólito Unanue2021-02-05info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/25510.33734/diagnostico.v59i4.255Diagnóstico; Vol. 59 No. 4 (2020); 194-197Diagnostico; Vol. 59 Núm. 4 (2020); 194-1971018-28882709-795110.33734/diagnostico.v59i4reponame:Diagnósticoinstname:Fundación Instituto Hipólito Unanueinstacron:FIHUspahttps://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/255/256Derechos de autor 2021 Luis A. Espinozainfo:eu-repo/semantics/openAccessoai:revistadiagnostico.fihu.org.pe:article/2552021-06-04T17:51:37Z |
| dc.title.none.fl_str_mv |
Epidemiology and clinical manifestations of SARS-CoV2 infection Epidemiología y manifestaciones clínicas de la infección por SARS-CoV-2 |
| title |
Epidemiology and clinical manifestations of SARS-CoV2 infection |
| spellingShingle |
Epidemiology and clinical manifestations of SARS-CoV2 infection Espinoza, Luis A. Pandemia COVID-19 COVID-19 pandemia |
| title_short |
Epidemiology and clinical manifestations of SARS-CoV2 infection |
| title_full |
Epidemiology and clinical manifestations of SARS-CoV2 infection |
| title_fullStr |
Epidemiology and clinical manifestations of SARS-CoV2 infection |
| title_full_unstemmed |
Epidemiology and clinical manifestations of SARS-CoV2 infection |
| title_sort |
Epidemiology and clinical manifestations of SARS-CoV2 infection |
| dc.creator.none.fl_str_mv |
Espinoza, Luis A. |
| author |
Espinoza, Luis A. |
| author_facet |
Espinoza, Luis A. |
| author_role |
author |
| dc.subject.none.fl_str_mv |
Pandemia COVID-19 COVID-19 pandemia |
| topic |
Pandemia COVID-19 COVID-19 pandemia |
| description |
Over the last year, the whole world has been affected by the COVID-19 pandemic, with over 80 million people affected with more than 1.8 million dead over the same period. Like other recent epidemics, this seems to be zoonotic in origin with the bats as the primary species harboring these coronaviruses but with a still unnamed intermediary host. Up to 80% of the cases have minor symptoms but 5% of the remainder may develop severe complications including respiratory failure. There has been a fast development of the knowledge about the disease in a very short period of time, making it a less lethal disease now as well as accelerating the development of several available vaccines. |
| publishDate |
2021 |
| dc.date.none.fl_str_mv |
2021-02-05 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
https://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/255 10.33734/diagnostico.v59i4.255 |
| url |
https://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/255 |
| identifier_str_mv |
10.33734/diagnostico.v59i4.255 |
| dc.language.none.fl_str_mv |
spa |
| language |
spa |
| dc.relation.none.fl_str_mv |
https://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/255/256 |
| dc.rights.none.fl_str_mv |
Derechos de autor 2021 Luis A. Espinoza info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
Derechos de autor 2021 Luis A. Espinoza |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
Fundación Instituto Hipólito Unanue |
| publisher.none.fl_str_mv |
Fundación Instituto Hipólito Unanue |
| dc.source.none.fl_str_mv |
Diagnóstico; Vol. 59 No. 4 (2020); 194-197 Diagnostico; Vol. 59 Núm. 4 (2020); 194-197 1018-2888 2709-7951 10.33734/diagnostico.v59i4 reponame:Diagnóstico instname:Fundación Instituto Hipólito Unanue instacron:FIHU |
| instname_str |
Fundación Instituto Hipólito Unanue |
| instacron_str |
FIHU |
| institution |
FIHU |
| reponame_str |
Diagnóstico |
| collection |
Diagnóstico |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1849061175760781312 |
| score |
12.788011 |
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).